recently a GWAS identified CTNNA3 as a susceptibility gene for airway hyperresponsiveness in toluene diisocyanate induced asthma [31], and mutations in CTTNA3 have been implicated in NSCL cancer [32]. The gene discussed is CTNNA3; the disease is asthma.